Anemia
📧 Sign up to get email alerts when something new happens for Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Improving Iron Status Through Consumption Of Iron Fortified Cowpea: An Intervention Study [NA]
A completed clinical trial evaluated whether consuming iron-fortified cowpea can improve iron status in people with anemia or low iron store…
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Improving Iron Status of Children: Potential of Amaranth [NA]
A completed clinical trial explored whether amaranth could improve iron status in children with anemia or iron deficiency anemia.
-
CLINICAL_TRIALS trial_result · 2011-09-19Clinical Trial Update: Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes [Phase 4]
A Phase 4 trial evaluated the interaction between iron and zinc supplementation and its effect on biochemical and clinical outcomes in indiv…
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Appropriate Complmentary Feeding Strategies in Infants [NA]
A completed clinical trial sponsored by Aga Khan University evaluating complementary feeding strategies in infants for anemia.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants [NA]
A completed clinical trial evaluated intermittent preventive treatment to prevent malaria and anemia in infants in Papua New Guinea.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot [Phase 4]
This is a completed Phase 4 clinical trial (CRIT Pilot) comparing conservative versus liberal red blood cell transfusion strategies in patie…
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Well Being of Obstetric Patients on Minimal Blood Transfusions [Phase 4]
The document reports the completion of a Phase 4 trial evaluating the well-being of obstetric patients managed with minimal blood transfusio…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia [Phase 4]
Phase 4 safety trial assessing epoetin alfa in cancer patients with chemotherapy-related anemia. The results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD) [Phase 4]
Phase 4 trial evaluating cinacalcet's ability to help end-stage renal disease patients meet K/DOQI targets for secondary hyperparathyroidism…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks [Phase 2]
This document reports the completion of a Phase 2 study evaluating the efficacy and safety of PROCRIT (epoetin alfa) in cancer patients rece…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy. [Phase 2]
Phase 2 trial comparing two dosing schedules of epoetin alfa (PROCRIT) in cancer patients with chemotherapy-induced anemia, evaluating effic…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks [Phase 2]
Phase 2 trial assessing the efficacy and safety of PROCRIT (epoetin alfa) in cancer patients receiving chemotherapy (weekly or every four we…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of epoetin alfa (PROCRIT) in cancer patients with anemia who are not receiving che…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study) [Phase 3]
Phase 3 study evaluating perioperative epoetin alfa (PROCRIT) for safety and efficacy in blood conservation during major elective spinal sur…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy [Phase 2]
Phase 2 trial assessing early and standard intervention with 120,000 units of epoetin alfa (PROCRIT) given every three weeks in chemotherapy…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia [Phase 2]
Phase II study in elderly patients with chronic anemia has been terminated. It aimed to assess changes in physical function.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients. [Phase 2]
Phase 2 pharmacokinetic/pharmacodynamic study of epoetin alfa (Procrit) in critically ill patients with anemia. The trial status is complete…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: The Duration Study [Phase 3]
The Duration Study, a Phase 3 trial sponsored by Johnson & Johnson Pharmaceutical Research & Development, has been terminated; results are n…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Treatment of Anemia in Diabetic Subjects With CKD [Phase 2]
A Phase 2 clinical trial evaluating treatment of anemia in diabetic subjects with chronic kidney disease was terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients [Phase 2]
A Phase 2 trial comparing PROCRIT (epoetin alfa) dosing every two weeks versus once weekly in anemic HIV-infected patients; the study was te…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia [Phase 2]
This Phase II trial evaluating changes in physical function in elderly patients with chronic anemia was terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: PROCRIT and Short-Term Outcomes in Orthopedic Surgery [Phase 2]
A Phase 2 trial evaluating PROCRIT (epoetin alfa) for short-term outcomes in orthopedic surgery was terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy. [Phase 3]
Phase 3 clinical trial evaluating the hematologic response (hemoglobin increase) to PROCRIT (epoetin alfa) given at 80,000 units weekly in c…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU) [Phase 3]
A Phase 3 trial evaluating a treatment for anemia in critically ill ICU patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer [Phase 2]
A completed Phase 2 study comparing epoetin alfa to placebo in patients with persistent anemia caused by advanced cancer to evaluate safety …